Join

Compare · LMDX vs NNNN

LMDX vs NNNN

Side-by-side comparison of LumiraDx Limited (LMDX) and Anbio Biotechnology (NNNN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both LMDX and NNNN operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • LMDX is the larger of the two at $2.23B, about 4.7x NNNN ($474.8M).
  • LMDX has more recent analyst coverage (4 ratings vs 0 for NNNN).
MetricLMDXNNNN
Company
LumiraDx Limited
Anbio Biotechnology
Price
-
-
Market cap
$2.23B
$474.8M
1M return
-
-
1Y return
-
-
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
2025
News (4w)
0
0
Recent ratings
4
0